SEARCH RESULTS FOR:
Rodrigo Nunes
COO, HOCHSCHILD MINING
"Our positive experience in Brazil has encouraged us to continue growing in the country."
Bernardo Viana
PARTNER, GE21 CONSULTORIA MINERAL
"Last year we saw significant project growth, particularly with rare earth elements."
Matuzalem Sukete
GENERAL MANAGER, ANGOLA ENVIRONMENTAL SERVIÇOS (AES)
"We are currently exploring opportunities in Namibia, where the growth of the oil and gas sector presents promising prospects."
Owuze Nwuche
CEO, MONTEGO ENERGY
"Competition is fierce, and the market is not growing much, which limits exploration and development opportunities."
Steffen Gjorvad
PRESIDENT, TAKRAF USA
"We are one of only two companies globally with active references on the gearless conveyor drive technology in operation. We have collaborated with ABB on various high-capacity and technical gearless drive projects."
Kung Chee Wan
CEO, OLEOCHEMICALS GOLDEN AGRI-RESOURCES (GAR)
"Golden Agri-Resources (GAR) is one of the world’s largest palm oil companies, managing over half a million hectares of palm oil plantations across Indonesia."
Jeant Peinado
BUSINESS MANAGER, CONFIPETROL
"We have developed an ambitious five-year business plan for Chile, identifying a potential market of over US$2 billion in services and potential tenders where we can participate."
Florencio Castro
PRESIDENT SOUTH AMERICA, MINERALS & METALS, AUSENCO
"We are seeing increasing demand from clients for assistance with decarbonization, tailings management and resource efficiency."
Anass Joundy
ASSOCIATE DIRECTOR, LEAD BANKER NATURAL RESOURCES, SOUTH & EAST MEDITERRANEAN REGION, EUROPEAN BANK OF RECONSTRUCTION AND DEVELOPMENT (EBRD)
"EBRD can act as a catalyst for project development since our stamp of approval influences others to also trust a promising mining project."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
